ArticleThe Journal of clinical investigation2026
Tescalcin is a phagocytic checkpoint driving immune escape and limiting immunotherapeutic efficacy in hepatocellular carcinoma.
Jiong-Liang Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.